Evidence map›Paper›PMID 24117880›Full record

ArticleJournal of periodontal research2014

Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease.

J Jin, X Zhang, Z Lu, Y Li, M F Lopes-Virella, H Yu, C J Haycraft, Q Li, K L Kirkwood, Y Huang

Open access · greenAbstract read
In one paragraph

Article in Journal of periodontal research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Curriculum Gaps in Periodontal Knowledge Among Medical Students: A Cross-Sectional Study.European journal of dental education : official journal of the Association for Dental Education in Europe · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Dentistry journal · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease.International journal of molecular sciences · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

J JinDivision of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, College of Medicine, Medical University of South Carolina, Charleston, SC, USA.
X Zhang
Z Lu
Y Li
M F Lopes-Virella
H Yu
C J Haycraft
Q Li
K L Kirkwood
Y Huang
Medical University of South Carolina · US

Funding

Pilot and Feasibility Project ProgramP30GM103331 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KIRKWOOD, KEITH L · 2012 to 2016
$5.2M
The Effect of Statin on Diabetes-Associated Peridontal DiseaseR01DE016353 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HUANG, YAN · 2005 to 2014
$3.3M
Post-Transcriptional Regulation of Periodontal DiseR01DE021423 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KIRKWOOD, KEITH L · 2011 to 2015
$2.1M
BLRD VA I01 BX000854NIDCR NIH HHS DE016353NIDCR NIH HHS R01 DE016353NIDCR NIH HHS R01 DE021423NIGMS NIH HHS P30 GM103331
6 · The paper itself

Abstract

BACKGROUND AND

objectiveStatins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase and have anti-inflammatory effects independent of cholesterol lowering. Recent clinical studies have indicated that statin intake has a beneficial effect on periodontal disease. However, the underlying mechanisms have not been well understood. In the current study, we employed a rat model with lipopolysaccharide (LPS)-induced periodontal disease and determined the effect of simvastatin, a commonly prescribed statin, on osteoclastogenesis, gingival inflammation and alveolar bone loss. MATERIAL AND

methodsSprague-Dawley rats were injected with Aggregatibacter actinomycetemcomitans LPS in periodontal tissue three times per week for 8 wk and part of the rats with LPS injection were also given simvastatin via gavage. After the treatments, the rat maxillae were scanned by microcomputed tomography and the images were analyzed to determine alveolar bone loss. To explore the underlying mechanisms, the effect of simvastatin on osteoclastogenesis and gingival expression of proinflammatory cytokines were also determined by tartrate-resistant acid phosphatase staining and real-time polymerase chain reaction assays, respectively.

resultsResults showed that LPS treatment markedly increased bone loss, but administration of simvastatin significantly alleviated the bone loss. Results also showed that LPS treatment stimulated osteoclastogenesis and the expression of inflammatory cytokines, but simvastatin significantly modulates the stimulatory effect of LPS on osteoclastogenesis and cytokine expression.

conclusionThis study demonstrated that simvastatin treatment inhibits LPS-induced osteoclastogenesis and gingival inflammation and reduces alveolar bone loss, indicating that the intake of simvastatin may hinder the progression of periodontal disease.

Indexed as

Acid PhosphataseAggregatibacter actinomycetemcomitansAlveolar Bone LossAnimalsAnti-Inflammatory AgentsCytokinesDisease Models, AnimalGingivaGingivitisHydroxymethylglutaryl-CoA Reductase InhibitorsInflammation MediatorsIsoenzymesLipopolysaccharidesMatrix Metalloproteinase 9Maxillary DiseasesOsteoclastsAcid PhosphataseAnti-Inflammatory AgentsCytokinesHydroxymethylglutaryl-CoA Reductase InhibitorsInflammation MediatorsIsoenzymesLipopolysaccharidesMatrix Metalloproteinase 9Mmp9 protein, ratSimvastatinTartrate-Resistant Acid PhosphataseToll-Like Receptorsalveolar boneinflammationlipopolysaccharideperiodontal diseasesimvastatin

Identifiers

PMID24117880
PMCPMC3979522
OpenAlexW2086171631

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.